Serial Number
78975805
Owner
Sibion biosciences GmbHAttorney
Beate Boudro, J.D.Filing Date
Feb 7, 2003
SIBION Trademark
Serial Number: 78975805 • Registration: 2950387
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Karl-Heinz-Beckurts-Strasse 13
Julich 52428 , DE
Entity Type: 10
Legal Representation
Trademark Details
Filing Date
February 7, 2003
Registration Date
May 10, 2005
Published for Opposition
March 23, 2004
Cancellation Date
December 16, 2011
Goods & Services
(Based on 44(e)) Electronic, electric, optical, chemical, biological and biochemical sensors for human, animal and plant material, for eucaryotic cells, for cells from microscopic small biopsies, for cells obtained from tissue samples, for cell culture lines, for chemically fixed tissues, for micrometastatic cells, for bone marrow cells, for body fluids, for stem cells, for cloned single cells and for differentiated stages from specific cells, namely, for biological, chemical, biochemical, biotechnological, medical and pharmaceutical research
Chemical and biological preparations, namely, extracts of cells and tissues and components thereof for scientific, research and industrial use; nucleic acids, peptides, proteins, cell lines for scientific purposes; diagnostic and analytic preparations for analysis and diagnosis for scientific purposes, namely, for the investigation and characterization of the molecular causes of diseases
(Based on 44(e)) Scientific and technological services, namely, diagnosis and analysis of animal and human diseases, cell differentiation of stem cells and other progenitor cells, steps in the development from micrometastatic cells to metastatic cells, characterization of the differentiated stages from specific cells, establishing of validated assay systems including cloning of target cDNA, transfection of target cDNA and implementation of biosensors, primary and secondary drug screening, selectivity screening against related targets, recording the kinetics of dose-response relations, determination of pharmacological parameters, identification of target structures for the development of medicaments, determination of the influence of various substances on the cell growth, proliferation, differentiation and secretion of molecules in various cell types, development of pharmaceuticals and medicaments, development of new technology for others in the fields of biology, chemistry, biochemistry, pharmacy, medicine, and biotechnology, licensing and research work in the fields of biomedicine and the search for pharmaceutically active agents